Published in J Gen Virol on November 01, 1993
Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol (1994) 4.20
Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol (2000) 3.88
Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol (1995) 2.70
Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J Virol (1996) 2.65
Translational control of viral gene expression in eukaryotes. Microbiol Mol Biol Rev (2000) 2.63
Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J (2003) 2.38
Bc1-2 protects mice against fatal alphavirus encephalitis. Proc Natl Acad Sci U S A (1996) 2.31
The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J Virol (1996) 2.25
Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein sigma 1. J Virol (1995) 2.14
NS1 protein of influenza A virus down-regulates apoptosis. J Virol (2002) 2.12
Apoptosis as a cause of death in measles virus-infected cells. J Virol (1995) 1.97
Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J Virol (1995) 1.88
Cytopathogenesis and inhibition of host gene expression by RNA viruses. Microbiol Mol Biol Rev (2000) 1.86
Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J Virol (1997) 1.78
Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J Exp Med (1995) 1.78
2009 H1N1 influenza. Mayo Clin Proc (2009) 1.76
Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg Infect Dis (2007) 1.72
bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation. J Virol (1996) 1.69
Influenza virus ns1 protein induces apoptosis in cultured cells. J Virol (2001) 1.67
Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases. Nat Med (2008) 1.64
Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B. J Virol (1995) 1.63
Reovirus-induced apoptosis is mediated by TRAIL. J Virol (2000) 1.62
Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells. J Virol (1999) 1.61
Host cell manipulation by the human pathogen Toxoplasma gondii. Cell Mol Life Sci (2008) 1.49
Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication. J Virol (2005) 1.47
African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. J Virol (1996) 1.39
Effect of enforced expression of human bcl-2 on Japanese encephalitis virus-induced apoptosis in cultured cells. J Virol (1997) 1.35
Characterization of a porcine lung epithelial cell line suitable for influenza virus studies. J Virol (2001) 1.33
Suppression of apoptosis in insect cells stably transfected with baculovirus p35: dominant interference by N-terminal sequences p35(1-76). J Virol (1994) 1.33
H5N1 avian influenza virus induces apoptotic cell death in mammalian airway epithelial cells. J Virol (2008) 1.32
Human lymphocyte apoptosis after exposure to influenza A virus. J Virol (2001) 1.31
Influenza A virus replication induces cell cycle arrest in G0/G1 phase. J Virol (2010) 1.30
Avian influenza virus A/HK/483/97(H5N1) NS1 protein induces apoptosis in human airway epithelial cells. J Virol (2008) 1.27
Induction of programmed cell death by parvovirus H-1 in U937 cells: connection with the tumor necrosis factor alpha signalling pathway. J Virol (1998) 1.27
A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead. BMC Public Health (2011) 1.27
Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J Virol (1996) 1.26
Increased induction of apoptosis by a Sendai virus mutant is associated with attenuation of mouse pathogenicity. J Virol (1998) 1.25
Amelioration of influenza virus pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol (2006) 1.24
Interferon induction and/or production and its suppression by influenza A viruses. J Virol (2005) 1.23
Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J Virol (2002) 1.16
Theiler's murine encephalomyelitis virus subgroup strain-specific infection in a murine macrophage-like cell line. J Virol (1997) 1.14
Virus clearance through apoptosis-dependent phagocytosis of influenza A virus-infected cells by macrophages. J Virol (2000) 1.14
Dynamics of biologically active subpopulations of influenza virus: plaque-forming, noninfectious cell-killing, and defective interfering particles. J Virol (2009) 1.13
Host immune and apoptotic responses to avian influenza virus H9N2 in human tracheobronchial epithelial cells. Am J Respir Cell Mol Biol (2010) 1.13
Open reading frame 5 of porcine reproductive and respiratory syndrome virus as a cause of virus-induced apoptosis. J Virol (1996) 1.09
Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture. BMC Public Health (2011) 1.09
Uses of flow cytometry in virology. Clin Microbiol Rev (1994) 1.09
The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming. J Exp Med (1998) 1.08
Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice. J Virol (2003) 1.05
Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J Virol (2002) 1.05
PA-X decreases the pathogenicity of highly pathogenic H5N1 influenza A virus in avian species by inhibiting virus replication and host response. J Virol (2015) 1.04
Severe acute respiratory syndrome coronavirus gene 7 products contribute to virus-induced apoptosis. J Virol (2007) 1.02
Induction of T-cell apoptosis by human herpesvirus 6. J Virol (1997) 1.01
Influenza virus induces apoptosis via BAD-mediated mitochondrial dysregulation. J Virol (2012) 1.01
Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation. PLoS One (2012) 0.97
Rapid death of duck cells infected with influenza: a potential mechanism for host resistance to H5N1. Immunol Cell Biol (2011) 0.95
Inhibition of NF-kappa B activity and cFLIP expression contribute to viral-induced apoptosis. Apoptosis (2005) 0.95
Highly pathogenic avian influenza A virus H5N1 NS1 protein induces caspase-dependent apoptosis in human alveolar basal epithelial cells. Virol J (2010) 0.95
Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model. PLoS One (2011) 0.94
Clonogenic assay of type a influenza viruses reveals noninfectious cell-killing (apoptosis-inducing) particles. J Virol (2008) 0.94
Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cytopathogenicity. J Virol (2010) 0.93
Infectious hematopoietic necrosis virus matrix protein inhibits host-directed gene expression and induces morphological changes of apoptosis in cell cultures. J Virol (2000) 0.92
Role of apoptosis in rabies viral encephalitis: a comparative study in mice, canine, and human brain with a review of literature. Patholog Res Int (2011) 0.91
Temporal changes in chromatin, intracellular calcium, and poly(ADP-ribose) polymerase during Sindbis virus-induced apoptosis of neuroblastoma cells. J Virol (1996) 0.91
Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin. J Immunol (2010) 0.90
Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Int J Nanomedicine (2013) 0.90
Early host responses of seasonal and pandemic influenza A viruses in primary well-differentiated human lung epithelial cells. PLoS One (2013) 0.89
Inhibition of double-stranded RNA- and tumor necrosis factor alpha-mediated apoptosis by tetratricopeptide repeat protein and cochaperone P58(IPK). Mol Cell Biol (1999) 0.89
The NS1 protein of influenza A virus interacts with heat shock protein Hsp90 in human alveolar basal epithelial cells: implication for virus-induced apoptosis. Virol J (2011) 0.87
Cell death regulation during influenza A virus infection by matrix (M1) protein: a model of viral control over the cellular survival pathway. Cell Death Dis (2011) 0.86
Phosphatidylserine-mediated phagocytosis of influenza A virus-infected cells by mouse peritoneal macrophages. J Virol (2000) 0.85
The nucleoprotein of influenza A virus induces p53 signaling and apoptosis via attenuation of host ubiquitin ligase RNF43. Cell Death Dis (2015) 0.85
Induction of apoptosis of T cells by infecting mice with murine cytomegalovirus. J Virol (1995) 0.85
Knockdown of specific host factors protects against influenza virus-induced cell death. Cell Death Dis (2013) 0.83
Lung epithelial cells resist influenza A infection by inducing the expression of cytochrome c oxidase VIc which is modulated by miRNA 4276. Virology (2014) 0.82
Rhabdovirus-induced apoptosis in a fish cell line is inhibited by a human endogenous acid cysteine proteinase inhibitor. J Virol (1997) 0.81
Lymphopenia associated with highly virulent H5N1 virus infection due to plasmacytoid dendritic cell-mediated apoptosis of T cells. J Immunol (2014) 0.81
Adenovirus E1B 19-kilodalton protein modulates innate immunity through apoptotic mimicry. J Virol (2013) 0.81
A reduction in the number of peripheral CD28+CD8+T cells in the acute phase of influenza. Clin Exp Immunol (2002) 0.80
Variations in genome-wide RNAi screens: lessons from influenza research. J Clin Bioinforma (2015) 0.80
Apoptosis in congestive heart failure induced by viral myocarditis in mice. Heart Vessels (1999) 0.79
PD-L1 expression induced by the 2009 pandemic influenza A(H1N1) virus impairs the human T cell response. Clin Dev Immunol (2013) 0.79
Analysis of host- and strain-dependent cell death responses during infectious salmon anemia virus infection in vitro. Virol J (2009) 0.79
Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer. Cancer Gene Ther (2011) 0.79
Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate. Med Microbiol Immunol (2010) 0.77
Host defense mechanism-based rational design of live vaccine. PLoS One (2013) 0.77
Synchrotron Infrared and Deep UV Fluorescent Microspectroscopy Study of PB1-F2 β-Aggregated Structures in Influenza A Virus-infected Cells. J Biol Chem (2016) 0.77
Detection of influenza virus induced ultrastructural changes and DNA damage. Indian J Virol (2010) 0.76
Networks of Host Factors that Interact with NS1 Protein of Influenza A Virus. Front Microbiol (2016) 0.76
Oncolytic activity of avian influenza virus in human pancreatic ductal adenocarcinoma cell lines. J Virol (2014) 0.76
Influenza A Virus and Influenza B Virus Can Induce Apoptosis via Intrinsic or Extrinsic Pathways and Also via NF-κB in a Time and Dose Dependent Manner. Biochem Res Int (2016) 0.75
A Lipidomics Approach in the Characterization of Zika-Infected Mosquito Cells: Potential Targets for Breaking the Transmission Cycle. PLoS One (2016) 0.75
Pretreatment of mice with oligonucleotide prop5 protects them from influenza virus infections. Viruses (2014) 0.75
Highly pathogenic avian influenza H5N1 virus delays apoptotic responses via activation of STAT3. Sci Rep (2016) 0.75
H1N1 infection associated with persistent lower respiratory tract illness in an infant with isolated IgA deficiency. BMJ Case Rep (2012) 0.75
Role of Autophagy and Apoptosis in the Postinfluenza Bacterial Pneumonia. Biomed Res Int (2016) 0.75
Bik Mediates Caspase-Dependent Cleavage of Viral Proteins to Promote Influenza A Virus Infection. Am J Respir Cell Mol Biol (2016) 0.75
Complexes of Oligoribonucleotides with D-Mannitol Inhibit Hemagglutinin-Glycan Interaction and Suppress Influenza A Virus H1N1 (A/FM/1/47) Infectivity In Vitro. Pharmaceuticals (Basel) (2017) 0.75
Induction of Apoptosis and Subsequent Phagocytosis of Virus-Infected Cells As an Antiviral Mechanism. Front Immunol (2017) 0.75
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother (1990) 11.71
Pipemidic acid, a new antibacterial agent active against Pseudomonas aeruginosa: in vitro properties. Antimicrob Agents Chemother (1975) 8.67
Pipemidic acid: its activities against various experimental infections. Antimicrob Agents Chemother (1976) 7.92
Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol (1990) 7.61
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet (1994) 7.07
Pipemidic acid: absorption, distribution, and excretion. Antimicrob Agents Chemother (1975) 6.38
Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol Gen Genet (1988) 6.30
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob Agents Chemother (1991) 6.19
Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol Gen Genet (1986) 5.95
In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid. Antimicrob Agents Chemother (1983) 5.45
Compartmental specificity of cellular membrane fusion encoded in SNARE proteins. Nature (2000) 4.67
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun (1993) 4.32
Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrob Agents Chemother (1994) 3.96
Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation (1995) 3.82
New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity. J Bacteriol (1981) 3.65
Discovery of a cool planet of 5.5 Earth masses through gravitational microlensing. Nature (2006) 3.53
Efficient promoter cassettes for enhanced expression of foreign genes in dicotyledonous and monocotyledonous plants. Plant Cell Physiol (1996) 3.30
Effective elimination of drug resistance and sex factors in Escherichia coli by sodium dodecyl sulfate. J Bacteriol (1968) 3.22
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res (1998) 3.20
Electric-field-induced superconductivity in an insulator. Nat Mater (2008) 3.17
Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids. Antimicrob Agents Chemother (1978) 3.12
AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science (1989) 2.93
Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem (1991) 2.89
The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci U S A (1999) 2.87
Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1996) 2.84
Molecular cloning and sequence determination of cDNAs for alpha subunits of the guanine nucleotide-binding proteins Gs, Gi, and Go from rat brain. Proc Natl Acad Sci U S A (1986) 2.83
Primary structure of elongation factor Tu from Escherichia coli. Proc Natl Acad Sci U S A (1980) 2.72
Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J Virol (1999) 2.65
Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol (1992) 2.60
Topological restriction of SNARE-dependent membrane fusion. Nature (2000) 2.58
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys. Antimicrob Agents Chemother (1983) 2.58
C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc Natl Acad Sci U S A (1994) 2.57
Isolation of a second yeast Saccharomyces cerevisiae gene (GPA2) coding for guanine nucleotide-binding regulatory protein: studies on its structure and possible functions. Proc Natl Acad Sci U S A (1988) 2.54
Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob Agents Chemother (1993) 2.48
Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun (1995) 2.42
Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol (2000) 2.36
Comparative study on adhesive performance of functional monomers. J Dent Res (2004) 2.32
Evolutionary adaptation of plasmid-encoded enzymes for degrading nylon oligomers. Nature (1984) 2.29
Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene (2007) 2.27
Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells. Proc Natl Acad Sci U S A (1990) 2.26
Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: final results of the primary angioplasty versus stent implantation in acute myocardial infarction (PASTA) trial. PASTA Trial Investigators. Catheter Cardiovasc Interv (1999) 2.23
Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck (1997) 2.21
Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol (2009) 2.20
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science (1988) 2.17
Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1990) 2.17
Occurrence in Saccharomyces cerevisiae of a gene homologous to the cDNA coding for the alpha subunit of mammalian G proteins. Proc Natl Acad Sci U S A (1987) 2.15
Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction. Eur Respir J (1997) 2.13
Surgical anatomy of the hepatic veins and the inferior vena cava. Surg Gynecol Obstet (1981) 2.12
Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet (1997) 2.12
Two polypeptides associated with the ribonucleic acid polymerase core of Bacillus subtilis during sporulation. J Bacteriol (1977) 2.10
Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol Cell Biol (1995) 2.10
Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. Proc Natl Acad Sci U S A (1997) 2.10
Discovery of a Jupiter/Saturn analog with gravitational microlensing. Science (2008) 2.09
Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia. Leuk Res (1999) 2.07
Unique features of the CAG repeats in Machado-Joseph disease. Nat Genet (1995) 2.06
Cloning and characterization of the cDNAs for human and rabbit interleukin-1 precursor. Nucleic Acids Res (1985) 2.06
Induction of osteogenic differentiation by hedgehog proteins. Biochem Biophys Res Commun (1997) 2.05
Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science (1992) 1.98
Detection of Norwalk-like virus genes in the caecum contents of pigs. Arch Virol (1998) 1.97
Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum (1996) 1.97
Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins. Haemostasis (1978) 1.96
Complete nucleotide sequence of the gene for human interleukin 1 alpha. Nucleic Acids Res (1986) 1.95
Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase. J Biol Chem (1994) 1.94
Malignant eccrine spiradenoma: a case report and review of the literature. Dermatol Surg (2001) 1.94
Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems. Proc Natl Acad Sci U S A (1999) 1.93
An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol (2000) 1.93
CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol Cell Biol (1994) 1.92
Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice. Antimicrob Agents Chemother (1983) 1.90
A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation (1996) 1.90
Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6. Mol Cell Biol (1988) 1.89
Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am J Psychiatry (2001) 1.89
Discovery of superconductivity in KTaO₃ by electrostatic carrier doping. Nat Nanotechnol (2011) 1.89
Relation between smoking status of physicians and their enthusiasm to offer smoking cessation advice. Intern Med (1997) 1.88
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science (1992) 1.85
Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. Am J Hematol (1998) 1.85
Congenital dislocation of the knee reduced spontaneously or with minimal treatment. J Pediatr Orthop (1997) 1.84
Nucleotide sequence and expression in Escherichia coli of the gene coding for sphingomyelinase of Bacillus cereus. Eur J Biochem (1988) 1.80
A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene (1999) 1.78
Treatment of herpes simplex esophagitis in an immunocompetent patient with intravenous acyclovir: a case report and review of the literature. Am J Gastroenterol (1998) 1.78
Evaluation of the new system (umu-test) for the detection of environmental mutagens and carcinogens. Mutat Res (1985) 1.76
Crystal structure of DNA photolyase from Anacystis nidulans. Nat Struct Biol (1997) 1.75
OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther (1998) 1.74
Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery (1994) 1.73
Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood (1992) 1.72
Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients. Stroke (1996) 1.71
Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc Natl Acad Sci U S A (1986) 1.71
Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. Int Immunol (1990) 1.71
Voxel-based analysis of MRI reveals anterior cingulate gray-matter volume reduction in posttraumatic stress disorder due to terrorism. Proc Natl Acad Sci U S A (2003) 1.69
Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a. Infect Immun (1987) 1.69
The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Morphological mechanism of senile plaque production. Virchows Arch B Cell Pathol Incl Mol Pathol (1982) 1.68
Isolation of morphologically intact mitochondrial nucleoids from the yeast, Saccharomyces cerevisiae. J Cell Sci (1987) 1.68
Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy. Circulation (1997) 1.68
Autoantibodies against thyroid hormones or iodothyronine. Implications in diagnosis, thyroid function, treatment, and pathogenesis. Ann Intern Med (1985) 1.67
Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett (1999) 1.66
Molecular analysis of expression of parental cell properties in hybrids between monocytes and a myeloma cell line. Somat Cell Mol Genet (1988) 1.65
Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells. Kidney Int (1998) 1.64
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med (2000) 1.64
Refined structure of cytochrome c3 at 1.8 A resolution. J Mol Biol (1984) 1.63
Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer (1998) 1.62
Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia. Leukemia (1998) 1.62